172 related articles for article (PubMed ID: 29177671)
1. Creation of Recombinant Chaperone Vaccine Using Large Heat Shock Protein for Antigen-Targeted Cancer Immunotherapy.
Guo C; Subjeck JR; Wang XY
Methods Mol Biol; 2018; 1709():345-357. PubMed ID: 29177671
[TBL] [Abstract][Full Text] [Related]
2. Enhancing antigen cross-presentation and T-cell priming by complexing protein antigen to recombinant large heat-shock protein.
Wang XY; Yi H; Yu X; Zuo D; Subjeck JR
Methods Mol Biol; 2011; 787():277-87. PubMed ID: 21898243
[TBL] [Abstract][Full Text] [Related]
3. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.
Wang XY; Chen X; Manjili MH; Repasky E; Henderson R; Subjeck JR
Cancer Res; 2003 May; 63(10):2553-60. PubMed ID: 12750279
[TBL] [Abstract][Full Text] [Related]
4. Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen.
Wang XY; Sun X; Chen X; Facciponte J; Repasky EA; Kane J; Subjeck JR
J Immunol; 2010 Jun; 184(11):6309-19. PubMed ID: 20439916
[TBL] [Abstract][Full Text] [Related]
5. Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-A and scavenger receptor expressed by endothelial cells-I.
Facciponte JG; Wang XY; Subjeck JR
Eur J Immunol; 2007 Aug; 37(8):2268-79. PubMed ID: 17615582
[TBL] [Abstract][Full Text] [Related]
6. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity.
Wang XY; Kazim L; Repasky EA; Subjeck JR
J Immunol; 2001 Jan; 166(1):490-7. PubMed ID: 11123328
[TBL] [Abstract][Full Text] [Related]
7. CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma.
Qian J; Yi H; Guo C; Yu X; Zuo D; Chen X; Kane JM; Repasky EA; Subjeck JR; Wang XY
J Immunol; 2011 Sep; 187(6):2905-14. PubMed ID: 21832164
[TBL] [Abstract][Full Text] [Related]
8. Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.
Manjili MH; Henderson R; Wang XY; Chen X; Li Y; Repasky E; Kazim L; Subjeck JR
Cancer Res; 2002 Mar; 62(6):1737-42. PubMed ID: 11912148
[TBL] [Abstract][Full Text] [Related]
9. HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice.
Manjili MH; Wang XY; Chen X; Martin T; Repasky EA; Henderson R; Subjeck JR
J Immunol; 2003 Oct; 171(8):4054-61. PubMed ID: 14530326
[TBL] [Abstract][Full Text] [Related]
10. High molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapy.
Wang XY; Subjeck JR
Int J Hyperthermia; 2013 Aug; 29(5):364-75. PubMed ID: 23829534
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum chaperone glucose regulated protein 170-Pokemon complexes elicit a robust antitumor immune response in vivo.
Yuan B; Xian R; Wu X; Jing J; Chen K; Liu G; Zhou Z
Immunobiology; 2012 Jul; 217(7):738-42. PubMed ID: 22317751
[TBL] [Abstract][Full Text] [Related]
12. Development of cancer vaccines using autologous and recombinant high molecular weight stress proteins.
Wang XY; Manjili MH; Park J; Chen X; Repasky E; Subjeck JR
Methods; 2004 Jan; 32(1):13-20. PubMed ID: 14624871
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with a chaperone complex based on PSCA and GRP170 adjuvant enhances the CTL response and inhibits the tumor growth in mice.
Huo W; Ye J; Liu R; Chen J; Li Q
Vaccine; 2010 Aug; 28(38):6333-7. PubMed ID: 20637304
[TBL] [Abstract][Full Text] [Related]
14. Enhanced endoplasmic reticulum entry of tumor antigen is crucial for cross-presentation induced by dendritic cell-targeted vaccination.
Wang H; Yu X; Guo C; Zuo D; Fisher PB; Subjeck JR; Wang XY
J Immunol; 2013 Dec; 191(12):6010-21. PubMed ID: 24218449
[TBL] [Abstract][Full Text] [Related]
15. Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease.
Wang XY; Kazim L; Repasky EA; Subjeck JR
Int J Cancer; 2003 Jun; 105(2):226-31. PubMed ID: 12673684
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 110 improves the antitumor effects of the cytotoxic T lymphocyte epitope E7(49-57) in mice.
Ren F; Xu Y; Mao L; Ou R; Ding Z; Zhang X; Tang J; Li B; Jia Z; Tian Z; Ni B; Wu Y
Cancer Biol Ther; 2010 Jan; 9(2):134-41. PubMed ID: 19901562
[TBL] [Abstract][Full Text] [Related]
17. A Novel Heat Shock Protein 70-based Vaccine Prepared from DC-Tumor Fusion Cells.
Weng D; Calderwood SK; Gong J
Methods Mol Biol; 2018; 1709():359-369. PubMed ID: 29177672
[TBL] [Abstract][Full Text] [Related]
18. The hsp110 and Grp1 70 stress proteins: newly recognized relatives of the Hsp70s.
Easton DP; Kaneko Y; Subjeck JR
Cell Stress Chaperones; 2000 Oct; 5(4):276-90. PubMed ID: 11048651
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of renal cell carcinoma vaccines targeting carbonic anhydrase IX using heat shock protein 110.
Kim HL; Sun X; Subjeck JR; Wang XY
Cancer Immunol Immunother; 2007 Jul; 56(7):1097-105. PubMed ID: 17146628
[TBL] [Abstract][Full Text] [Related]
20. Chaperoning function of stress protein grp170, a member of the hsp70 superfamily, is responsible for its immunoadjuvant activity.
Park JE; Facciponte J; Chen X; MacDonald I; Repasky EA; Manjili MH; Wang XY; Subjeck JR
Cancer Res; 2006 Jan; 66(2):1161-8. PubMed ID: 16424054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
